MANHATTAN ASSOCIATES INC (MANH) Stock Fundamental Analysis

NASDAQ:MANH • US5627501092

139.61 USD
+4.31 (+3.19%)
At close: Feb 26, 2026
139.61 USD
0 (0%)
After Hours: 2/26/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to MANH. MANH was compared to 274 industry peers in the Software industry. Both the health and profitability get an excellent rating, making MANH a very profitable company, without any liquidiy or solvency issues. MANH is not valued too expensively and it also shows a decent growth rate. This makes MANH very considerable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year MANH was profitable.
  • MANH had a positive operating cash flow in the past year.
  • MANH had positive earnings in each of the past 5 years.
  • MANH had a positive operating cash flow in each of the past 5 years.
MANH Yearly Net Income VS EBIT VS OCF VS FCFMANH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • With an excellent Return On Assets value of 26.20%, MANH belongs to the best of the industry, outperforming 98.18% of the companies in the same industry.
  • MANH has a Return On Equity of 69.88%. This is amongst the best in the industry. MANH outperforms 97.45% of its industry peers.
  • MANH has a better Return On Invested Capital (58.53%) than 99.27% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MANH is significantly above the industry average of 10.80%.
  • The 3 year average ROIC (56.95%) for MANH is below the current ROIC(58.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 26.2%
ROE 69.88%
ROIC 58.53%
ROA(3y)27.08%
ROA(5y)24.87%
ROE(3y)68.78%
ROE(5y)61.46%
ROIC(3y)56.95%
ROIC(5y)51.03%
MANH Yearly ROA, ROE, ROICMANH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • MANH has a better Profit Margin (20.34%) than 84.31% of its industry peers.
  • In the last couple of years the Profit Margin of MANH has grown nicely.
  • MANH has a better Operating Margin (26.15%) than 89.42% of its industry peers.
  • MANH's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 56.32%, MANH is doing worse than 65.33% of the companies in the same industry.
  • MANH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.15%
PM (TTM) 20.34%
GM 56.32%
OM growth 3Y9.51%
OM growth 5Y6.09%
PM growth 3Y6.54%
PM growth 5Y6.46%
GM growth 3Y1.86%
GM growth 5Y0.86%
MANH Yearly Profit, Operating, Gross MarginsMANH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MANH is creating value.
  • Compared to 1 year ago, MANH has less shares outstanding
  • Compared to 5 years ago, MANH has less shares outstanding
  • MANH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MANH Yearly Shares OutstandingMANH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
MANH Yearly Total Debt VS Total AssetsMANH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 12.71 indicates that MANH is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 12.71, MANH belongs to the best of the industry, outperforming 93.80% of the companies in the same industry.
  • There is no outstanding debt for MANH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.71
ROIC/WACC5.34
WACC10.97%
MANH Yearly LT Debt VS Equity VS FCFMANH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • MANH has a Current Ratio of 1.28. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.28, MANH is doing worse than 61.31% of the companies in the same industry.
  • MANH has a Quick Ratio of 1.28. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
  • MANH has a worse Quick ratio (1.28) than 60.58% of its industry peers.
  • MANH does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
MANH Yearly Current Assets VS Current LiabilitesMANH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 7.19% over the past year.
  • MANH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.57% yearly.
  • Looking at the last year, MANH shows a small growth in Revenue. The Revenue has grown by 3.75% in the last year.
  • MANH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.02% yearly.
EPS 1Y (TTM)7.19%
EPS 3Y22.47%
EPS 5Y23.57%
EPS Q2Q%3.42%
Revenue 1Y (TTM)3.75%
Revenue growth 3Y12.13%
Revenue growth 5Y13.02%
Sales Q2Q%5.7%

3.2 Future

  • MANH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.98% yearly.
  • MANH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.85% yearly.
EPS Next Y4.92%
EPS Next 2Y8.89%
EPS Next 3Y10.37%
EPS Next 5Y18.98%
Revenue Next Year6.47%
Revenue Next 2Y7.63%
Revenue Next 3Y8.05%
Revenue Next 5Y8.85%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MANH Yearly Revenue VS EstimatesMANH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
MANH Yearly EPS VS EstimatesMANH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 27.54, the valuation of MANH can be described as expensive.
  • Based on the Price/Earnings ratio, MANH is valued a bit cheaper than 61.68% of the companies in the same industry.
  • MANH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.11, which is the current average of the S&P500 Index.
  • MANH is valuated quite expensively with a Price/Forward Earnings ratio of 26.25.
  • The rest of the industry has a similar Price/Forward Earnings ratio as MANH.
  • MANH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.54
Fwd PE 26.25
MANH Price Earnings VS Forward Price EarningsMANH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • MANH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MANH is cheaper than 66.42% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MANH indicates a somewhat cheap valuation: MANH is cheaper than 70.07% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.34
EV/EBITDA 27.77
MANH Per share dataMANH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of MANH may justify a higher PE ratio.
PEG (NY)5.6
PEG (5Y)1.17
EPS Next 2Y8.89%
EPS Next 3Y10.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MANH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MANHATTAN ASSOCIATES INC

NASDAQ:MANH (2/26/2026, 8:00:00 PM)

After market: 139.61 0 (0%)

139.61

+4.31 (+3.19%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-27
Earnings (Next)04-20
Inst Owners104.35%
Inst Owner Change-2.58%
Ins Owners1.2%
Ins Owner Change-0.94%
Market Cap8.36B
Revenue(TTM)1.08B
Net Income(TTM)219.95M
Analysts83.16
Price Target221.82 (58.89%)
Short Float %3.55%
Short Ratio2.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.54%
Min EPS beat(2)5.72%
Max EPS beat(2)13.36%
EPS beat(4)4
Avg EPS beat(4)11.67%
Min EPS beat(4)5.72%
Max EPS beat(4)13.93%
EPS beat(8)8
Avg EPS beat(8)14.56%
EPS beat(12)12
Avg EPS beat(12)18.24%
EPS beat(16)16
Avg EPS beat(16)21.82%
Revenue beat(2)0
Avg Revenue beat(2)-0.34%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)-0.17%
Revenue beat(4)2
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)1.26%
Revenue beat(8)4
Avg Revenue beat(8)0.46%
Revenue beat(12)8
Avg Revenue beat(12)1.99%
Revenue beat(16)12
Avg Revenue beat(16)2.69%
PT rev (1m)-0.72%
PT rev (3m)-3.74%
EPS NQ rev (1m)-8.98%
EPS NQ rev (3m)-10.06%
EPS NY rev (1m)-1.63%
EPS NY rev (3m)-3.03%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 27.54
Fwd PE 26.25
P/S 7.73
P/FCF 22.34
P/OCF 21.45
P/B 26.55
P/tB 33.09
EV/EBITDA 27.77
EPS(TTM)5.07
EY3.63%
EPS(NY)5.32
Fwd EY3.81%
FCF(TTM)6.25
FCFY4.48%
OCF(TTM)6.51
OCFY4.66%
SpS18.07
BVpS5.26
TBVpS4.22
PEG (NY)5.6
PEG (5Y)1.17
Graham Number24.49
Profitability
Industry RankSector Rank
ROA 26.2%
ROE 69.88%
ROCE 73.73%
ROIC 58.53%
ROICexc 410.13%
ROICexgc N/A
OM 26.15%
PM (TTM) 20.34%
GM 56.32%
FCFM 34.59%
ROA(3y)27.08%
ROA(5y)24.87%
ROE(3y)68.78%
ROE(5y)61.46%
ROIC(3y)56.95%
ROIC(5y)51.03%
ROICexc(3y)364.11%
ROICexc(5y)380.76%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)71.74%
ROCE(5y)64.28%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-0.52%
ROICexc growth 5Y23.6%
OM growth 3Y9.51%
OM growth 5Y6.09%
PM growth 3Y6.54%
PM growth 5Y6.46%
GM growth 3Y1.86%
GM growth 5Y0.86%
F-Score7
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 244.69%
Cap/Sales 1.43%
Interest Coverage 250
Cash Conversion 134.74%
Profit Quality 170.05%
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z 12.71
F-Score7
WACC10.97%
ROIC/WACC5.34
Cap/Depr(3y)154.87%
Cap/Depr(5y)122.75%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.85%
Profit Quality(3y)145.98%
Profit Quality(5y)147.21%
High Growth Momentum
Growth
EPS 1Y (TTM)7.19%
EPS 3Y22.47%
EPS 5Y23.57%
EPS Q2Q%3.42%
EPS Next Y4.92%
EPS Next 2Y8.89%
EPS Next 3Y10.37%
EPS Next 5Y18.98%
Revenue 1Y (TTM)3.75%
Revenue growth 3Y12.13%
Revenue growth 5Y13.02%
Sales Q2Q%5.7%
Revenue Next Year6.47%
Revenue Next 2Y7.63%
Revenue Next 3Y8.05%
Revenue Next 5Y8.85%
EBIT growth 1Y8.08%
EBIT growth 3Y22.8%
EBIT growth 5Y19.9%
EBIT Next Year9.29%
EBIT Next 3Y11.81%
EBIT Next 5Y13.03%
FCF growth 1Y30.62%
FCF growth 3Y29.3%
FCF growth 5Y22.03%
OCF growth 1Y32.02%
OCF growth 3Y29.44%
OCF growth 5Y22.55%

MANHATTAN ASSOCIATES INC / MANH FAQ

Can you provide the ChartMill fundamental rating for MANHATTAN ASSOCIATES INC?

ChartMill assigns a fundamental rating of 7 / 10 to MANH.


What is the valuation status for MANH stock?

ChartMill assigns a valuation rating of 4 / 10 to MANHATTAN ASSOCIATES INC (MANH). This can be considered as Fairly Valued.


How profitable is MANHATTAN ASSOCIATES INC (MANH) stock?

MANHATTAN ASSOCIATES INC (MANH) has a profitability rating of 9 / 10.


How financially healthy is MANHATTAN ASSOCIATES INC?

The financial health rating of MANHATTAN ASSOCIATES INC (MANH) is 9 / 10.


What is the expected EPS growth for MANHATTAN ASSOCIATES INC (MANH) stock?

The Earnings per Share (EPS) of MANHATTAN ASSOCIATES INC (MANH) is expected to grow by 4.92% in the next year.